FierceBiotech

Medtronic, BD to collaborate on diabetes infusion set featuring enhanced insulin delivery

Medtronic ($MDT) will commercialize Becton Dickinson's ($BDX) insulin pump infusion set with FlowSmart technology, the companies announced at the annual meeting of ...
PR Newswire

New Clinical Data Suggest Infusion Set with BD FlowSmart™ Technology May Improve Insulin Flow and Reduce Silent Occlusions

BOSTON, June 6, 2015 /PRNewswire/ -- BD Medical, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), released research on infusion sets that ...
FierceBiotech

FDA clears BD insulin infusion set developed with diabetes patient advocacy groups

Becton Dickinson ($BDX) worked with diabetes patient advocate groups to develop its latest insulin infusion set, which is designed for improved insulin flow with ...
Yahoo Finance

BD (BDX) Receives FDA Nod to Address Critical Infusion Needs

Becton, Dickinson and Company BDX, popularly known as BD, recently received the FDA’s 510(k) clearance for its updated BD Alaris Infusion System. This is expected to enable both remediation and a ...
Yahoo Finance

BD expands Class I recall to cover 15 more Alaris pump infusion sets

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD has expanded a Class I Alaris recall to cover 15 ...
Healio

BD receives funding for insulin infusion therapy improvements

BD will be entering into a new research partnership with JDRF to improve insulin infusion sets, according to a company press release. “Insulin infusion therapy has substantial clinical benefits for ...
PR Newswire

BD and Medtronic Collaborate to Introduce a New Infusion Set with BD FlowSmart™ Technology Designed to Improve Insulin Pump Therapy

BOSTON, June 8, 2015 /PRNewswire/ -- BD Medical, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), and Medtronic (NYSE: MDT) today announced a ...
USA Today

BD Provides Update on Voluntary Recall of Certain BD Alaris™ Pump Infusion Sets

FRANKLIN LAKES, N.J. (Sept. 12, 2025) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today expanded their Class I voluntary recall initiated in the ...
Diabetes.co.uk

Infusion Sets

The infusion set is an important part of the pump. Infusion sets should only be used once and usually need to be changed within 2 or 3 days. Infusion sets are the parts of an insulin pump that go on ...
Healio

Extended-wear insulin infusion set lasts 7 days for most wearers, with few adverse events

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A novel extended-wear insulin infusion set was usable ...
Business Wire

Capillary Biomedical Reports Best-in-Class Clinical Feasibility Results for its SteadiFlow Seven-Day-Wear Infusion Set Technology at ADA Scientific Sessions

IRVINE, Calif.--(BUSINESS WIRE)--Medical device developer Capillary Biomedical, Inc. (CapBio) has presented highly favorable clinical feasibility study results for its SteadiFlow cannula technology at ...